Asuransi Mandiri Proteksi Penyakit Tropis

Asuransi Mandiri Proteksi Penyakit Tropis is a season-specific safety net for endemic Indonesian tropical diseases — most importantly dengue (demam berdarah) during the October-to-March rainy season, plus typhoid, malaria, hepatitis A, measles, chikungunya, and Zika. Strip away the “asuransi kesehatan individu” label and what remains is narrow and honest: this product reimburses inpatient hospital bills if — and only if — the cause of admission is one of seven named tropical diseases. It is not comprehensive health insurance. It is not critical-illness lump-sum. It is not a substitute for hospitalization cover. It is a low-cost top-up policy — premium starts at Rp 100,000 per month for the entry plan — with a very specific use-case: covering the gap between BPJS economy-class care and private-room hospitalization when a household member contracts a tropical disease. Sold at Bank Mandiri counters and via telemarketing, the product is renewable annually until the insured turns 70 and offers an optional Manfaat Pengembalian Premi (ROP) that returns 30% of the last 36 months of premium at policy years 3, 6, 9, and so on if no claim has been filed. For Legacy Income agents the strategic read is straightforward: this is a niche secondary-cover pitch for mass-market families with kids in dengue-endemic areas, sold alongside BPJS or as a private-room top-up for households that cannot stretch to full hospitalization premiums.

---

The RIPLAY publishes two illustrations on the same insured — Bapak Faldhy, 35-year-old male, Plan III, annual premium. Illustration 1 selects the ROP rider at Rp 2,300,000/year. Illustration 2 omits ROP at Rp 1,750,000/year. Decoded in vertical stat blocks:

Critical insight for the agent narrative: this product makes economic sense only if a tropical-disease hospitalization actually occurs at private-room rates. Without a claim, ROP refunds about 30% of premium every three years — a soft cushion, not a savings instrument. Customers who frame this as protection-plus-savings will be disappointed. Frame it as cheap insurance against a specific, seasonal, real risk — dengue hits roughly 100,000+ Indonesians per year and a single private-room hospitalization can wipe out a month of household income.

---

Sweet Spot — Lead with Mandiri Proteksi Penyakit Tropis

• Families with school-age children in dengue-endemic urban areas: Greater Jakarta, Surabaya, Medan, Bandung, Makassar — kids are the highest-incidence cohort.
• Mass-market households where the breadwinner has BPJS Kelas 2 or Kelas 3 but no private hospitalization insurance — premium of Rp 100,000–Rp 200,000 per month is digestible where Rp 1 million per month is not.
• Customers buying as secondary cover alongside BPJS — they want the option of a Kamar Kelas 1 / private room if a child catches dengue, but cannot afford comprehensive medical premiums.
• Households with multiple children — adding covered lives is cheap on a per-life basis and dengue/typhoid risk scales with number of school-age kids.
• Existing Bank Mandiri customers approached at branch or via telemarketing — the product is bancassurance-native; cross-sell friction is low.
• Annual-budget customers who prefer one-shot premium decisions — annual renewal lets them re-evaluate every year rather than committing to a 10-year policy.

Borderline Fit — Discuss but qualify carefully

• Customers who think this replaces comprehensive health insurance — it does not. Walk through the seven-disease scope and confirm understanding before any close.
• Customers wanting cover for heart disease, kidney failure, cancer, stroke, or any non-tropical condition — all excluded. If they want broad CI cover, this is the wrong product.
• Customers who routinely seek medical treatment overseas — coverage is ASEAN. Treatment in Hong Kong, Australia, US, EU, China, India, Korea, Japan, Taiwan is excluded.
• Customers expecting bigger per-claim payouts — even Plan IV caps room at Rp 1,000,000 per day and annual benefit at Rp 50,000,000. Mid-tier private hospitals in Jakarta routinely exceed this on a multi-day ICU stay.
• Customers with strong existing health insurance — the no-double-claim rule (manfaat tunai only when another policy is in play) means significant overlap waste.

Do Not Pitch

• Customers seeking comprehensive medical cover — route to a full inpatient/outpatient hospitalization product. Mandiri Proteksi Penyakit Tropis covers only seven conditions and will leave them exposed for everything else.
• Customers wanting a CI lump-sum payout — this is a reimbursement product. There is no lump-sum cash transfer on diagnosis. If they want lump-sum CI, route to Allianz Critical Plus, Manulife Best Critical Care, or equivalent.
• Customers planning to seek treatment in Hong Kong, Korea, Japan, or any non-ASEAN destination — geographically excluded.
• Customers likely to lapse within 12 months — annual renewability softens the blow vs a 10-year structure, but ROP needs three claim-free years to deliver any value. Sub-12-month customers get nothing back.
• Customers who already hold a hospitalization plan that covers infectious / tropical diseases — overlap waste; manfaat tunai is the only payout available and the duplicate-coverage clause caps it.

---

Rule of thumb: trigger words for opening the Penyakit Tropis conversation are “DBD” (demam berdarah), “tifus”, “anak sakit musim hujan” (kids sick in rainy season), “asuransi tambahan murah” (cheap supplemental insurance), and “BPJS aja cukup nggak ya” (is BPJS alone enough). Trigger words to redirect away are “warisan” (legacy — wrong product), “investasi” (investment — wrong category), “kanker” or “jantung” (cancer / heart — different products in the AXA Mandiri shelf).

---

The critical-illness category at this project’s catalogue includes 25 agency products. PDF extraction coverage has not crossed the 60% threshold for quantitative aggregation, and the category itself is structurally heterogeneous — full-condition CI lump-sum policies, single-condition reimbursement products (Mandiri Proteksi Jantung, Mandiri Proteksi Kanker Dini, this product), and hybrid CI riders all coexist under the label. Direct quantitative benchmarking is misleading. The reading below is qualitative.

Confidence note: structural-dimension claims are high-confidence (drawn directly from RIPLAY). Competitor-comparison claims are analyst assessment from category knowledge, not directly benchmarked against parsed competitor RIPLAYs. The “no published competitor” claim is at the catalogue level — there may be off-shelf or new bancassurance products outside the project’s scan. Refresh trigger: re-run when (a) AXA Mandiri publishes a brochure, (b) covered-disease list is extended, or © a comparable competitor product is catalogued.

---

Opening — establish the right frame

“When the rainy season comes, every parent in Jakarta knows somebody whose child ended up in hospital with dengue. The hospital bill at a private room can run Rp 10 to Rp 15 million for four nights — sometimes more. BPJS covers Kelas 3. What I’d like to talk about is a small policy that covers the gap. It costs less than Rp 5,000 per day for the entry plan.”

“Kalau musim hujan datang, setiap orang tua di Jakarta pasti kenal seseorang yang anaknya masuk rumah sakit karena DBD. Tagihan rumah sakit di kamar privat bisa Rp 10 sampai Rp 15 juta untuk empat malam — kadang lebih. BPJS hanya tanggung kelas 3. Yang ingin saya bahas adalah polis kecil yang tutup gap ini. Premi paling murah kurang dari Rp 5.000 per hari.”

The seven-disease scope (honest framing up front)

“I want to be clear from the start: this policy only covers seven diseases — dengue, typhoid, malaria, hepatitis A, measles, chikungunya, and Zika. It does not cover cancer, heart disease, kidney problems, or general flu. It is a focused, low-cost top-up — it is not a substitute for full health insurance. The reason it is cheap is exactly because the scope is narrow. If you want broader cover, I will show you a different product.”

“Saya mau jujur dari awal: polis ini hanya menanggung tujuh penyakit — DBD, tifus, malaria, hepatitis A, campak, chikungunya, dan Zika. Tidak menanggung kanker, jantung, masalah ginjal, atau flu biasa. Ini adalah top-up yang fokus dan murah — bukan pengganti asuransi kesehatan penuh. Justru karena cakupannya sempit, preminya murah. Kalau Anda ingin cakupan yang lebih luas, saya akan tunjukkan produk lain.”

The proportional-room rule (set expectations early)

“There is one rule that matters at claim time. Each plan has a maximum room rate per day — Plan III is Rp 750,000 per day. If you stay in a more expensive room — say Rp 1,000,000 per day — the insurer pays 750 over 1,000, which is 75% of every line on your bill. You pay the rest. It is not a punishment, it is a proportional rule. I am telling you now so you know what to expect at the hospital.”

“Ada satu aturan penting saat klaim. Setiap plan punya batas maksimum biaya kamar per hari — Plan III misalnya Rp 750.000 per hari. Kalau Anda ambil kamar yang lebih mahal — misalnya Rp 1.000.000 per hari — asuransi bayar 750 dibagi 1.000, yaitu 75% dari setiap pos tagihan. Sisanya Anda bayar sendiri. Ini bukan hukuman, ini aturan proporsional. Saya kasih tahu sekarang biar Anda tahu apa yang akan terjadi di rumah sakit.”

Rainy season pitch (October–March seasonal opener)

“We are heading into rainy season. Health offices across Jakarta report a 2x to 3x jump in dengue cases between October and March compared to dry months. If your kids are in primary or secondary school, the exposure is highest in the school yard. The policy is annual, the entry premium is Rp 100,000 per month, and protection starts after a 30-day waiting period — so the time to decide is now, not in February when your neighbour’s child is already in hospital.”

“Kita sudah masuk musim hujan. Dinas Kesehatan Jakarta mencatat lonjakan kasus DBD 2 sampai 3 kali lipat antara Oktober dan Maret dibandingkan bulan kering. Kalau anak Anda di SD atau SMP, paparan tertinggi di sekolah. Polisnya tahunan, premi mulai Rp 100.000 per bulan, dan proteksi aktif setelah masa tunggu 30 hari — jadi waktunya memutuskan sekarang, bukan Februari nanti saat anak tetangga sudah masuk rumah sakit.”

The ROP rider (the “soft savings” frame)

“There is an optional add-on called Manfaat Pengembalian Premi. Pay an extra Rp 600,000 per year on top of the base premium, and at the end of every third year — if you have not made a claim — the insurer refunds 30% of the last 36 months of premium. It is not a savings product. It is a discount mechanism that softens the cost if you do not claim. Decide based on whether you think you are more likely to claim or not claim in any 3-year window.”

“Ada tambahan opsional namanya Manfaat Pengembalian Premi. Bayar ekstra Rp 600.000 per tahun di atas premi dasar, dan di akhir setiap tahun ke-3 — kalau tidak ada klaim — asuransi kembalikan 30% dari premi 36 bulan terakhir. Ini bukan produk tabungan. Ini mekanisme diskon yang melunakkan biaya kalau Anda tidak klaim. Tentukan berdasarkan apakah Anda merasa lebih mungkin klaim atau tidak dalam 3 tahun.”

—

1. “I already have BPJS — why add this?”

Customer “Saya sudah punya BPJS — kenapa perlu tambah ini?”

Don't say “BPJS is not enough.” — this fights a programme the customer values and the government supports.

Don't say “BPJS tidak cukup.”

Do say “BPJS is a good base — I have it too. The question is what class of room your family ends up in if your child catches dengue. BPJS at Kelas 3 means a shared room with 4 to 6 other patients. If your child is 7 years old, scared, and has a fever for four days, Kelas 1 or a private room makes a real difference. This policy pays for that upgrade — at Plan III, up to Rp 750,000 per day in room cost. It is not replacing BPJS. It is buying you the option of a quieter room when it matters.”

Do say “BPJS itu fondasi yang baik — saya juga punya. Pertanyaannya, kalau anak Anda kena DBD, di kamar kelas berapa keluarga Anda akan berada? BPJS Kelas 3 berarti kamar bersama dengan 4 sampai 6 pasien lain. Kalau anak Anda 7 tahun, takut, demam empat hari, kamar Kelas 1 atau privat itu beda banget. Polis ini bayar upgrade itu — di Plan III sampai Rp 750.000 per hari biaya kamar. Bukan menggantikan BPJS. Ini beli opsi kamar yang lebih tenang saat dibutuhkan.”

—

2. “Only 7 diseases? What about COVID, flu, or other infections?”

Customer “Cuma 7 penyakit? Bagaimana dengan COVID, flu, atau infeksi lain?”

Don't say “Those will be added later.” — you cannot promise insurer roadmap changes.

Don't say “Nanti akan ditambah.”

Do say “You are right — this is narrow. Seven specific tropical diseases, nothing else. COVID, regular flu, pneumonia, food poisoning, and other infections are not covered. The reason this product exists at this price is exactly because the scope is narrow. If you want cover for everything, the right answer is a full hospitalization plan — premium runs five to ten times higher per month, and I can quote you that separately. Or you keep this as your tropical-disease layer and add a hospital plan when budget allows. Both are valid; I will not pretend this product covers things it does not.”

Do say “Anda benar — cakupannya sempit. Tujuh penyakit tropis spesifik, tidak lebih. COVID, flu biasa, pneumonia, keracunan makanan, dan infeksi lain tidak ditanggung. Justru karena cakupannya sempit, harganya bisa segini. Kalau Anda mau cakupan menyeluruh, jawaban yang benar adalah plan rawat inap penuh — preminya 5 sampai 10 kali lipat per bulan, dan saya bisa quote terpisah. Atau Anda pertahankan ini sebagai lapisan penyakit tropis dan tambah plan rumah sakit saat budget memungkinkan. Dua-duanya valid; saya tidak akan pura-pura produk ini menanggung sesuatu yang tidak ditanggung.”

—

3. “Plan III pays Rp 30M a year — but my niece’s dengue cost Rp 8M at BPJS plus a private room. The premium isn’t worth it.”

Customer “Plan III bayar Rp 30 juta setahun — tapi keponakan saya kena DBD habis Rp 8 juta di BPJS plus kamar privat. Preminya nggak worth it.”

Don't say “Hospital bills are rising.” — vague and unverifiable.

Don't say “Biaya rumah sakit naik terus.”

Do say “Your niece’s number sounds right for a moderate case at a mid-tier hospital. The reason Plan III’s cap is Rp 30 million is the cases that are not moderate — DBD with shock syndrome that requires ICU for two days, or pneumonia complication on top of typhoid, or a re-infection that hospitalises an adult for a week. Those bills run Rp 20 to Rp 40 million at a private hospital. You are not buying this for the Rp 8 million case. You are buying it for the Rp 25 million case that you cannot predict. Premium of Rp 1.7 million per year is the price of removing that tail risk.”

Do say “Angka keponakan Anda masuk akal untuk kasus moderat di rumah sakit menengah. Plan III cap-nya Rp 30 juta karena kasus yang tidak moderat — DBD dengan shock syndrome yang butuh ICU dua hari, atau pneumonia komplikasi tifus, atau infeksi ulang yang rawat inap orang dewasa seminggu. Tagihan begitu Rp 20 sampai Rp 40 juta di rumah sakit privat. Anda bukan beli ini untuk kasus Rp 8 juta. Anda beli ini untuk kasus Rp 25 juta yang tidak bisa diprediksi. Premi Rp 1,7 juta setahun itu harga untuk hilangkan tail risk itu.”

—

4. “If I choose a room above Plan III’s Rp 750k/day cap, I pay proportionally? That’s weird — explain.”

Customer “Kalau saya ambil kamar di atas batas Plan III Rp 750 ribu per hari, saya bayar proporsional? Itu aneh — coba jelaskan.”

Don't say “It is in the contract.” — dismissive and breeds distrust.

Don't say “Itu sudah tertulis di kontrak.”

Do say “Fair question. It is called BKP over BKA — biaya kamar plan over biaya kamar aktual. Plan III pays room up to Rp 750,000 per day. If you pick a Rp 1,000,000 per day room, the insurer’s contribution is 750 divided by 1,000, which is 75%. That 75% applies not only to the room — it applies to every line on your hospital bill: doctor visits, medication, lab tests, ICU charges. So a Rp 20 million total bill becomes Rp 15 million reimbursed, Rp 5 million paid by you. The rule is there because room class drives the whole bill — a Rp 1 million-per-day room usually means more expensive doctors and more expensive lab tests too. If you want full reimbursement up to the annual cap, stay within the plan’s room limit. If you want a fancier room, the proportional rule applies. I would rather explain this now than have you surprised at the hospital.”

Do say “Pertanyaan yang valid. Namanya BKP berbanding BKA — biaya kamar plan berbanding biaya kamar aktual. Plan III tanggung kamar sampai Rp 750.000 per hari. Kalau Anda pilih kamar Rp 1.000.000 per hari, kontribusi asuransi adalah 750 dibagi 1.000, yaitu 75%. Tujuh-puluh-lima persen itu berlaku bukan hanya untuk kamar — berlaku untuk setiap pos tagihan rumah sakit: visite dokter, obat, lab, ICU. Jadi tagihan total Rp 20 juta jadi Rp 15 juta diganti, Rp 5 juta Anda bayar sendiri. Aturan ini ada karena kelas kamar dorong seluruh tagihan — kamar Rp 1 juta sehari biasanya berarti dokter lebih mahal dan lab lebih mahal juga. Kalau Anda mau penggantian penuh sampai cap tahunan, tetap di dalam batas kamar plan. Kalau mau kamar yang lebih bagus, aturan proporsional berlaku. Saya lebih baik jelaskan sekarang daripada Anda kaget di rumah sakit.”

—

5. “Should I get this or full hospitalization insurance?”

Customer “Saya mending ambil ini atau asuransi rawat inap penuh?”

Don't say “Get both.” — sounds like upselling.

Don't say “Ambil dua-duanya.”

Do say “If you can afford full hospitalization premium — typically Rp 8 to Rp 25 million per year for a family — get the full plan. It covers everything including tropical diseases, so this product becomes redundant. If full hospitalization is not in this year’s budget, this product at Rp 1 to Rp 2 million per year is a meaningful layer for the single most common rainy-season risk for your family. It is not a substitute, it is a stepping stone. Many of my customers start here and upgrade to full hospitalization in two or three years when income grows. The honest comparison is: this fills a specific gap cheaply; full hospitalization covers the whole problem at much higher cost. Tell me your monthly budget and I will tell you which fits.”

Do say “Kalau budget Anda muat untuk premi rawat inap penuh — biasanya Rp 8 sampai Rp 25 juta setahun untuk satu keluarga — ambil plan penuh. Itu menanggung semuanya termasuk penyakit tropis, jadi produk ini jadi redundant. Kalau rawat inap penuh belum masuk budget tahun ini, produk ini Rp 1 sampai Rp 2 juta setahun adalah lapisan yang berarti untuk risiko musim hujan paling umum bagi keluarga Anda. Bukan pengganti, ini batu loncatan. Banyak nasabah saya mulai di sini dan upgrade ke rawat inap penuh dua sampai tiga tahun lagi saat penghasilan tumbuh. Perbandingan jujurnya: ini tutup gap spesifik dengan murah; rawat inap penuh tanggung seluruh masalah dengan biaya jauh lebih tinggi. Sebutkan budget bulanan Anda, saya kasih tahu yang mana cocok.”

—

These are the issues most likely to trigger an OJK complaint or churn-back from a customer in 2026 under the tightened conduct rules. Build agent training around avoiding all of them.

1. Narrow disease scope must be disclosed up front. The mandatory disclosure is “this covers ONLY these 7 diseases: dengue, typhoid, malaria, hepatitis A, measles, chikungunya, Zika — no other illness is covered.” Walk through the list at open and ask the customer to confirm understanding before any close. A customer who later claims for COVID, pneumonia, or any non-listed condition and discovers no payout will file an OJK complaint, and that complaint will succeed if scope was not clearly disclosed.

2. BKP / BKA proportional reimbursement formula is non-trivial and is the single most common confusion point at claim time. The customer must understand that exceeding the plan’s room cap reduces reimbursement on every line of the bill proportionally — not just the room line. Walk through one numeric example at SPAJ. Get verbal confirmation. Mis-selling claims around BKP/BKA are predictable.

3. Daily cash and reimbursement are mutually exclusive within any single hospitalization. Specifically: if the insured holds another policy covering the same medical condition, this policy pays only the daily cash benefit and does not also reimburse hospital bills. Customers who hold two policies and expect both to pay in full will be disappointed.

4. Coverage geography must be stated clearly. Per the RIPLAY, the wilayah pertanggungan is ASEAN — Vietnam, Laos, Cambodia, Thailand, Myanmar, Malaysia, Indonesia, Singapore, Philippines, Timor-Leste, and Brunei Darussalam. Treatment in Hong Kong, Japan, Korea, Australia, the US, the EU, China, India, and Taiwan is excluded. Customers who travel cross-border for treatment must understand this before close.

5. POJK 36/2025 co-payment regime applies. Single-disease reimbursement products fall within POJK 36/2025 scope. Verify network compliance and ensure the SPAJ paperwork reflects current OJK conduct requirements. Co-payment language should be calibrated to the regulation, not left vague.

6. OJK conduct-of-business tightening for bancassurance and telemarketing. Distribution is bancassurance at Bank Mandiri counters plus telemarketing. Both channels are under OJK conduct-of-business scrutiny in 2026. Verbal consent must be recorded, scope must be disclosed in the recorded call, and the customer’s right to a 20-day cooling-off period must be stated explicitly.

7. ROP cliff at year 3. Early lapses lose all ROP value — the rider refunds 30% of the last 36 months only at the end of the third policy year and every three years after. A customer who lapses at month 30 has paid the higher ROP-inclusive premium for 30 months and gets nothing back. Do not sell ROP to customers with income volatility or short-term budget pressure; sell the no-ROP variant instead.

---

---

1. Build a seasonal-trigger pitch script for rainy season (October–March) — bilingual EN/ID. Anchor on dengue case-count data (Dinas Kesehatan publishes monthly), kid-cohort risk language, and the Rp 100,000–Rp 200,000 per month price point. Distribute to agents by 1 October ahead of the next rainy-season cycle.

2. Build a “BPJS vs Penyakit Tropis vs full hospitalization” decision tree for agent training. One page, three columns, side-by-side comparison of monthly premium, what is covered, who it fits, and clear “if X then Y” routing logic. This decision tree is the single highest-leverage agent training asset for this product class because the redirect logic is where most mis-selling complaints originate.

3. Train agents on the BKP / BKA proportional formula — script a five-minute role-play that walks through the Plan III room-upgrade scenario. Every agent should be able to compute the proportional reimbursement on a Rp 1,000,000 per day room without a calculator. This is the single largest source of customer confusion at claim time in this product category.

4. Compare against Allianz, Manulife, Prudential, AIA, Tokio Marine tropical-disease equivalents (if any). Initial scan suggests AXA Mandiri owns the published agency-catalogue niche; confirm with a deeper category scan and identify whether any insurer is preparing to enter. If the niche stays uncontested, the upsell narrative (“the only tropical-disease-specific product in Indonesia”) strengthens; if a competitor enters, refresh the brief immediately.

5. Refresh trigger — re-run this brief when AXA Mandiri publishes a brochure, extends the covered-disease list beyond the current seven, changes the price grid, modifies the BKP/BKA mechanic, or releases a Plan V. Also refresh if POJK 36/2025 enforcement specifics change in a way that affects single-disease reimbursement products.

---